Detailed Information
Cited 3 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Lazertinib, a 3rd generation EGFR-TKI, in patients with EGFR-TKI resistant NSCLC: Updated results of phase I/II Study.
- Authors
- Ahn, Myung-Ju; Han, Ji-Youn; Kim, Sang-We; Lee, Ki Hyeong; Kim, Dong-Wan; Lee, Yun-Gyoo; Cho, Eun Kyung; Lee, Gyeong-won; Lee, Jong-Seok; Kim, Joo-Hang; Kim, Jin-Soo; Min, Young Joo; Lee, Sung Sook; Shin, Sang Won; Kim, HyeRyun; Hong, Min Hee; Ahn, Jin Seok; Lee, Seoung Oh; Kim, Sohee; Cho, Byoung Chul
- Issue Date
- 20-May-2019
- Publisher
- American Society of Clinical Oncology
- Keywords
- Lazertinib; T790M; 3rd generation EGFR TKI
- Citation
- Journal of Clinical Oncology, v.37, no.15
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- Journal of Clinical Oncology
- Volume
- 37
- Number
- 15
- ISSN
- 0732-183X
1527-7755
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.